VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet

Completed

Conditions: Obesity
Ketogenic Dieting
Fatty Liver

Interventions: Other: Fibroscan changes with different diets

First Posted Date: 2017-05-04

Last Posted Date: 2020-03-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 54

Registration Number: NCT03141008

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Project UPLIFT to Reduce Anxiety and Depression in CF Patients

Not Applicable

Completed

Conditions: Cystic Fibrosis
Anxiety
Depression

Interventions: Behavioral: Treatment as usual
Behavioral: UPLIFT

First Posted Date: 2017-05-03

Last Posted Date: 2023-06-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 85

Registration Number: NCT03139266

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants

Not Applicable

Terminated

Conditions: Noninvasive Ventilation
Low Birth Weight

Interventions: Device: Neurally Adjusted Ventilatory Assist
Device: Nasal Intermittent Positive Pressure Ventilation

First Posted Date: 2017-05-02

Last Posted Date: 2019-11-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 1

Registration Number: NCT03137225

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E

Phase 4

Completed

Conditions: Abortion, Second Trimester

Interventions: Drug: Vaginal Misoprostol
Drug: Buccal Misoprostol

First Posted Date: 2017-04-28

Last Posted Date: 2018-07-18

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 70

Registration Number: NCT03134183

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Anxiety, Mood, and Health Behaviors in Young Adults

Not Applicable

Completed

Conditions: Anxiety Sensitivity

Interventions: Behavioral: Aerobic Exercise

First Posted Date: 2017-04-25

Last Posted Date: 2019-11-25

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 69

Registration Number: NCT03128437

Locations: 🇺🇸
Virginia Commonwealth University, School of Medicine, Richmond, Virginia, United States

Effects of Liothyronine on Energy Expenditure and Cardiovascular Function

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebos
Drug: Liothyronine
Drug: Levothyroxine

First Posted Date: 2017-03-31

Last Posted Date: 2021-03-26

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 22

Registration Number: NCT03098433

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT

Not Applicable

Terminated

Conditions: Metastatic Brain Tumor
Cerebral Metastases

Interventions: Behavioral: Physical Activity
Behavioral: Cognitive rehabilitation

First Posted Date: 2017-03-30

Last Posted Date: 2018-07-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 2

Registration Number: NCT03096431

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Ramelteon for Treatment of Insomnia in Cirrhosis

Phase 4

Completed

Conditions: Cirrhosis

Interventions: Drug: Ramelteon Pill

First Posted Date: 2017-03-27

Last Posted Date: 2021-03-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT03091738

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy

Active, not recruiting

Conditions: Congenital Myotonic Dystrophy

Interventions: Other: Natural history

First Posted Date: 2017-02-23

Last Posted Date: 2024-10-04

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 100

Registration Number: NCT03059264

Locations: 🇮🇹
Centro Clinico Nemo, Milano, Italy
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇨🇦
Pediatric Neuromuscular Research, Children's Hospital - LHSC, London, Ontario, Canada

Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease

Phase 2

Withdrawn

Conditions: Renal Disease, End Stage
Heart Failure, Systolic
Chronic Kidney Diseases

Interventions: Drug: Anakinra

First Posted Date: 2017-02-23

Last Posted Date: 2019-05-17

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT03062176

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy